top of page

ABOUT

Medical & Research Advances

Genetic Testing & Epilepsy 

Genetic testing is transforming the way we understand and treat epilepsy, especially for people with early-onset, drug-resistant, or unexplained seizures. Research shows that up to 40% of epilepsy cases may have a genetic cause—insight that can lead to more accurate diagnoses, personalized treatment options, and connections to emerging therapies12.

Modern genetic testing methods—such as epilepsy gene panels, whole-exome sequencing (WES), and whole-genome sequencing (WGS)—can detect mutations linked to specific epilepsy syndromes like Dravet syndrome, Lennox-Gastaut syndrome, or GEFS+ (generalized epilepsy with febrile seizures plus). Identifying these mutations can help doctors avoid medications that may worsen seizures and consider alternative treatments or clinical trials2.

The American College of Medical Genetics and Genomics (ACMG) recommends considering genetic testing if:

  • Seizures began in infancy or early childhood

  • The epilepsy is drug-resistant

  • There are additional developmental or neurological challenges

  • There’s a known or suspected family history of seizures or epilepsy3

How Do You Get Genetic Testing?

Genetic testing typically starts with a referral from your neurologist, epileptologist, or genetic counselor. They can help determine whether testing is appropriate and which type is best. Testing is often done using a simple blood sample or cheek swab, which is then analyzed by a certified genetics lab.

Some insurance plans cover genetic testing when it’s considered medically necessary—especially for drug-resistant or childhood-onset epilepsy. If insurance doesn’t cover it, some labs offer financial assistance or reduced-cost programs. You can also ask your care team about participating in research studies that include no-cost genetic testing.

If you or your loved one has epilepsy and you're curious about genetic testing, talk to your healthcare provider. A diagnosis can open doors to treatment options, peace of mind, and a stronger support network.

​

Footnotes

  1. Poduri, A., & Lowenstein, D. H. (2011). Epilepsy genetics—past, present, and future. Current Opinion in Genetics & Development, 21(3), 325–332. 

  2. Perucca, P., Bahlo, M., & Berkovic, S. F. (2020). The genetics of epilepsy. Annual Review of Genomics and Human Genetics, 21, 205–230. 

  3. ACMG Board of Directors. (2021). Clinical practice resources for the genetic evaluation of epilepsy. American College of Medical Genetics and Genomics. 

​

​

ABOUT

Emerging Treatments & Clinical Trials

Mayo Clinic researchers lead transformative shift toward neurorestorative treatment strategies for most severe forms of epilepsy

The Mayo Clinic is pioneering new regenerative medicine approaches to treat drug-resistant epilepsy (DRE), which affects roughly 15 million people worldwide. Traditional treatments like surgery and neuromodulation can be effective but often come with serious side effects and rarely lead to seizure freedom.

Mayo Clinic researchers are leading two innovative clinical trials:

​

  1. In Arizona, Dr. Jonathon Parker is testing the use of implanted inhibitory brain cells in patients with focal epilepsy. This minimally invasive treatment aims to repair neural circuitry and reduce seizures without impairing speech, memory, or motor skills. Early participants like Anthony Maita have tolerated the procedure well, though results are still being evaluated.

  2. In Florida, Dr. Sanjeet Grewal is exploring a combination of deep brain stimulation (DBS) and adipose-derived stem cell therapy. This is the first trial of its kind, with patient Tabitha Wilson being the first in the world to receive both treatments simultaneously in the thalamus. Stem cells may aid seizure control by healing damaged brain tissue via paracrine signaling.

Drs. Parker and Grewal emphasize that while it’s early in the research, these regenerative therapies offer new hope for those with severe epilepsy. Their long-term goal: safer, more effective treatments—and ultimately, a potential cure.

 

More information: 

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-lead-transformative-shift-toward-neurorestorative-treatment-strategies-for-most-severe-forms-of-epilepsy/

Placeholder Text

At Young Adults with Epilepsy (YAWE), our mission is to foster resilience and independence in young adults with epilepsy from

ABOUT

ABOUT

Books, Film, and TV

At Young Adults with Epilepsy (YAWE), our mission is to foster resilience and independence in young adults with epilepsy from

bottom of page